User profiles for "author:Giancarlo Scognamiglio"

Giancarlo Scognamiglio

MD, PhD AORN dei Colli - Monaldi Hospital
Verified email at ospedalideicolli.it
Cited by 1654

Acquired cardiovascular disease in adults with congenital heart disease: A call to action for timely preventive measures—a clinical consensus statement of the …

M Brida, S De Rosa, A Legendre… - European Heart …, 2023 - academic.oup.com
Rates of successful surgical repair and life expectancy for patients with congenital heart
disease have increased dramatically in recent decades. Thanks to advances in diagnosis …

Pattern of ascending aortic dimensions predicts the growth rate of the aorta in patients with bicuspid aortic valve

A Della Corte, C Bancone, M Buonocore… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: This study sought to identify risk factors for rapid growth of the ascending aorta in
patients with bicuspid aortic valve (BAV) disease, taking into account its phenotypic …

Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study

A Kempny, CS Hjortshøj, H Gu, W Li, AR Opotowsky… - Circulation, 2017 - Am Heart Assoc
Background: Eisenmenger syndrome is associated with substantial morbidity and mortality.
There is no consensus, however, on mortality risk stratification. We aimed to investigate …

Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology

M D'Alto, E Romeo, P Argiento, B Sarubbi… - International journal of …, 2012 - Elsevier
OBJECTIVES: The aim of the present study was to evaluate the safety, tolerability, clinical
and haemodynamic impact of add-on sildenafil in patients with congenital heart disease …

Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension

M D'Alto, K Dimopoulos, W Budts, GP Diller, G Di Salvo… - Heart, 2016 - heart.bmj.com
Pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease (CHD)
is associated with increased morbidity and mortality. The present review aims to discuss the …

Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe

H Yang, GR Veldtman, BJ Bouma, W Budts, K Niwa… - Open …, 2019 - openheart.bmj.com
Background In Fontan patients with atrial arrhythmias (AA), non-vitamin K antagonist oral
anticoagulants (NOACs) have a class III recommendation according to the Pediatric & …

[HTML][HTML] Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide …

H Yang, BJ Bouma, K Dimopoulos, P Khairy… - International journal of …, 2020 - Elsevier
Background Current guidelines consider vitamin K antagonists (VKA) the oral anticoagulant
agents of choice in adults with atrial arrhythmias (AA) and moderate or complex forms of …

Treatment of type B aortic dissection: endoluminal repair or conventional medical therapy?

G Dialetto, FE Covino, G Scognamiglio… - European journal of …, 2005 - academic.oup.com
Objective: To evaluate the mid-term results of endovascular stent-grafting for type B aortic
dissection, in comparison with those of standard medical therapy in uncomplicated cases …

Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome

M D'Alto, E Romeo, P Argiento, A D'Andrea… - International journal of …, 2013 - Elsevier
BACKGROUND: Oral bosentan is effective in pulmonary arterial hypertension (PAH) related
to congenital heart disease (CHD). In patients with Down's syndrome, the effect of bosentan …

Aortic and left ventricular remodeling in patients with bicuspid aortic valve without significant valvular dysfunction: a prospective study

G Santarpia, G Scognamiglio, G Di Salvo… - International journal of …, 2012 - Elsevier
BACKGROUND: Bicuspid aortic valve (BAV) represents the most common cardiac
congenital malformation in the adult age. It is frequently associated with dilatation, aneurysm …